Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Men are more likely than women to undergo mastectomy when diagnosed with breast cancer, a study published in the International Journal of Radiation Oncology • Biology • Physics revealed. The study is the largest to date to focus on treatment and outcomes for men with breast cancer in the United States.
Women with early-stage breast cancer treated with lumpectomy followed by radiation may live longer than those receiving mastectomy alone or with radiation, researchers found.Their study, published in the journal JAMA Surgery, compared the risk of dying from breast cancer over 10 years.
Less financially secure young women who self-detect a breast change are more likely to delay seeking help, according to a recent study.
Among women with early-stage breast cancer that travels to one or more lymph nodes in the underarm, treatment with the chemotherapy medicines doxorubicin (Adriamycin) followed by docetaxel (Taxotere) may lengthen survival more than giving the two at once. This finding comes from long-term results of the Breast International Group (BIG) trial 02-98.
A study of North Carolinian women found that young African-American women were far more likely to have breast cancer treatment delay than White women in the same age range of 20 to 49.
Those enrolled in the federally-run Pre-Existing Condition Insurance Plan (PCIP) now have 2 additional months of coverage, government officials announced. Coverage will continue through March 31, 2014, to ensure people can continue their medical treatment while finding and enrolling in new health plans through state marketplaces/exchanges.
Most women feel some level of pain 1 year after breast cancer surgery, Finnish researchers found. They hope their findings, published in the Journal of the American Medical Association, help inspire new ways of preventing and treating pain to improve quality of life after surgery.
Women at high risk of developing breast cancer should now be able to get medicines to help prevent it at no cost, the U.S. Department of Health and Human Services announced.
Women 65 and older received the same treatment benefit from the combination of pertuzumab (Perjeta), trastuzumab (Herceptin) and docetaxel (Taxotere) as women 64 and younger, a sub-analysis of CLEOPATRA trial data reveals.
Each December, medical experts and researchers from around the world meet at the 5-day San Antonio Breast Cancer Symposium to share the latest findings from breast cancer clinical trials. Read on for updates from the 2013 symposium, held December 10–14.